Fuse Medical (FZMD) Stock Price, News & Analysis
Company Description
Fuse Medical (OTC Link: FZMD) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $7.4M.
FZMD has declined 77.0% over the past year. Shares last traded at $0.0230.
For FY2022, Fuse Medical reported revenue of $18.6M with net income of $3.1M and diluted earnings per share of $0.04. The company operates at a net profit margin of 16.6%.
This page collects what Stock Titan holds for FZMD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Fuse Medical (FZMD) stock last closed at $0.0230. Over the past 12 months, the stock has lost 77.0%. At a market capitalization of $7.4M, FZMD is classified as a micro-cap stock with approximately 73.9M shares outstanding.
Latest News
Fuse Medical has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, fda approval. View all FZMD news →
SEC Filings
Financial Highlights
Fuse Medical generated $18.6M in revenue in FY2022, retaining a 61.9% gross margin, operating income reached -$815K (-4.4% operating margin), and net income was $3.1M, reflecting a 16.6% net profit margin. Diluted earnings per share stood at $0.04. The company generated $35K in operating cash flow. With a current ratio of 1.11, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Days to Cover History
FZMD Company Profile & Sector Positioning
Fuse Medical (FZMD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing FZMD often look at related companies in the same sector, including Alr Technologies (ALRTF), Adm Tronics (ADMT), NUGEN MEDICAL DEVICES INC (NGMDF), Remsleep Holding (RMSL), and Stimcell Energetics (STME). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FZMD's relative position within its industry.